Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stroke 1Liver Failure 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

veliparib 1urinastatin 1sacituzumab govitecan 1maltodextrin 1halofantrine 1Taxes 1Raltegravir Potassium 1Paclitaxel 1N-monoacetylcystine 1Glycyrrhizic Acid 1Everolimus 1Carboplatin 1Amino Acids 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Liver Failure × urinastatin × Clear all
NCT01643447 2016-03-31

Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)

Eastern Hepatobiliary Surgery Hospital

Phase NA Completed
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡